YC seed, before Demo Day
We invest ahead of Demo Day and help founders convert early momentum into strong seed rounds.
Spotlighting Miracle: How USA Olympic Archer Turned Founder Jin Kim Is Accelerating Clinical Trials
Biotech is one of the hardest industries to break into...regulated, slow, compliance-heavy, and notoriously resistant to new software. Yet Jin Kim, a solo YC founder, is doing what few believed possible: building a profitable, fast-growing AI platform that transforms how biotech companies run clinical trials.
Featured Startups
Select portfolio companies we're excited to highlight from recent batches.
Why us
- Pre–Demo Day access. We commit before the crowd, when speed and conviction matter most.
- Signal you can show. Weekly Spotlight creates investor pull.
- Founder‑friendly, clean terms. Optimized for speed and minimal distraction.
Latest Updates
Follow our latest investments, portfolio updates, and market insights.
For investors
Strategy: concentrated pre–Demo Day positions in standout YC startups; software‑first across AI, infra/devtools, fintech, and vertical SaaS.
Edge: systematic batch coverage, early references from builders and customers, and a public Spotlight that helps our companies raise efficiently.
Portfolio development: hands‑on Demo Day prep and targeted early customers; we aim to be the first outside capital in each position.
Reporting: monthly Spotlight, quarterly LP letters, and timely material updates.
Structure: standard seed terms; QSBS eligibility for qualifying positions (consult your tax advisor).
Subscribe to Seed Spotlight
Weekly YC batch intel and a handful of picks. Unsubscribe anytime.
